| Rhodes M Kriete, MD | |
|
1223 Gateway Dr, Melbourne, FL 32901-2607 | |
| (321) 725-4500 | |
| (321) 722-3843 |
| Full Name | Rhodes M Kriete |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 36 Years |
| Location | 1223 Gateway Dr, Melbourne, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447241120 | NPI | - | NPPES |
| 372955900 | Medicaid | FL | |
| 390005080 | Other | FL | RR MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | ME63696 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Palm Bay Kidney Center | Palm bay, FL | Dialysis facility |
| Melbourne Kidney Center | Melbourne, FL | Dialysis facility |
| North Melbourne Dialysis Inc | Melbourne, FL | Dialysis facility |
| Holmes Regional Medical Center | Melbourne, FL | Hospital |
| Melbourne Regional Medical Center | Melbourne, FL | Hospital |
| Viera Hospital | Melbourne, FL | Hospital |
| Cape Canaveral Hospital | Cocoa beach, FL | Hospital |
| Palm Bay Hospital | Palm bay, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Florida Kidney Physicians Llc | 4385925650 | 140 |
News Archive
NPR's "Morning Edition" on Tuesday examined revisions to the Medicaid programs in Kentucky and West Virginia, which are the first two states to revise their programs under a new federal law that allows states increased flexibility in determining benefits and out-of-pocket costs (Rovner, "Morning Edition," NPR, 8/22).
Cancers sometimes escape our immune defenses because of the over-activity of molecular signaling systems, called checkpoint processes. Now we may be able to fight back using a new range of molecules, researchers in China report in the European Journal of Medicinal Chemistry.
P.A.D. occurs when arteries in the legs become narrowed or clogged with fatty deposits, reducing blood flow to the legs. This can result in leg muscle pain when walking, disability, amputation, and poor quality of life. Blocked arteries found in people with P.A.D. can be a red flag that other arteries, including those in the heart and brain, may also be blocked - increasing the risk of a heart attack or stroke.
Digna Biotech and the Centro de Investigacion Medica Aplicada (CIMA) de la Universidad de Navarra announced today that the European Union (EU) has finalized a EUR 3.3 million grant to AIPGENE consortium. Digna Biotech and CIMA will receive, as members of the consortium, EUR 0.5 and EUR 0.8 million respectively for the clinical development of a gene therapy product for Acute Intermittent Porphyria (AIP).
A radioactive bone cement that's injected into bone to provide support and local irradiation is proving to be a safer alternative to conventional radiation therapy for bone tumors, according to a study led by University of California, Irvine researchers.
› Verified 6 days ago
| Entity Name | Florida Kidney Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760831564 PECOS PAC ID: 4385925650 Enrollment ID: O20161228000460 |
News Archive
NPR's "Morning Edition" on Tuesday examined revisions to the Medicaid programs in Kentucky and West Virginia, which are the first two states to revise their programs under a new federal law that allows states increased flexibility in determining benefits and out-of-pocket costs (Rovner, "Morning Edition," NPR, 8/22).
Cancers sometimes escape our immune defenses because of the over-activity of molecular signaling systems, called checkpoint processes. Now we may be able to fight back using a new range of molecules, researchers in China report in the European Journal of Medicinal Chemistry.
P.A.D. occurs when arteries in the legs become narrowed or clogged with fatty deposits, reducing blood flow to the legs. This can result in leg muscle pain when walking, disability, amputation, and poor quality of life. Blocked arteries found in people with P.A.D. can be a red flag that other arteries, including those in the heart and brain, may also be blocked - increasing the risk of a heart attack or stroke.
Digna Biotech and the Centro de Investigacion Medica Aplicada (CIMA) de la Universidad de Navarra announced today that the European Union (EU) has finalized a EUR 3.3 million grant to AIPGENE consortium. Digna Biotech and CIMA will receive, as members of the consortium, EUR 0.5 and EUR 0.8 million respectively for the clinical development of a gene therapy product for Acute Intermittent Porphyria (AIP).
A radioactive bone cement that's injected into bone to provide support and local irradiation is proving to be a safer alternative to conventional radiation therapy for bone tumors, according to a study led by University of California, Irvine researchers.
› Verified 6 days ago
| Entity Name | Space Coast Nephrology Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821552696 PECOS PAC ID: 1355681032 Enrollment ID: O20190315000082 |
News Archive
NPR's "Morning Edition" on Tuesday examined revisions to the Medicaid programs in Kentucky and West Virginia, which are the first two states to revise their programs under a new federal law that allows states increased flexibility in determining benefits and out-of-pocket costs (Rovner, "Morning Edition," NPR, 8/22).
Cancers sometimes escape our immune defenses because of the over-activity of molecular signaling systems, called checkpoint processes. Now we may be able to fight back using a new range of molecules, researchers in China report in the European Journal of Medicinal Chemistry.
P.A.D. occurs when arteries in the legs become narrowed or clogged with fatty deposits, reducing blood flow to the legs. This can result in leg muscle pain when walking, disability, amputation, and poor quality of life. Blocked arteries found in people with P.A.D. can be a red flag that other arteries, including those in the heart and brain, may also be blocked - increasing the risk of a heart attack or stroke.
Digna Biotech and the Centro de Investigacion Medica Aplicada (CIMA) de la Universidad de Navarra announced today that the European Union (EU) has finalized a EUR 3.3 million grant to AIPGENE consortium. Digna Biotech and CIMA will receive, as members of the consortium, EUR 0.5 and EUR 0.8 million respectively for the clinical development of a gene therapy product for Acute Intermittent Porphyria (AIP).
A radioactive bone cement that's injected into bone to provide support and local irradiation is proving to be a safer alternative to conventional radiation therapy for bone tumors, according to a study led by University of California, Irvine researchers.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rhodes M Kriete, MD 1223 Gateway Dr, Melbourne, FL 32901-2607 Ph: (321) 725-4500 | Rhodes M Kriete, MD 1223 Gateway Dr, Melbourne, FL 32901-2607 Ph: (321) 725-4500 |
News Archive
NPR's "Morning Edition" on Tuesday examined revisions to the Medicaid programs in Kentucky and West Virginia, which are the first two states to revise their programs under a new federal law that allows states increased flexibility in determining benefits and out-of-pocket costs (Rovner, "Morning Edition," NPR, 8/22).
Cancers sometimes escape our immune defenses because of the over-activity of molecular signaling systems, called checkpoint processes. Now we may be able to fight back using a new range of molecules, researchers in China report in the European Journal of Medicinal Chemistry.
P.A.D. occurs when arteries in the legs become narrowed or clogged with fatty deposits, reducing blood flow to the legs. This can result in leg muscle pain when walking, disability, amputation, and poor quality of life. Blocked arteries found in people with P.A.D. can be a red flag that other arteries, including those in the heart and brain, may also be blocked - increasing the risk of a heart attack or stroke.
Digna Biotech and the Centro de Investigacion Medica Aplicada (CIMA) de la Universidad de Navarra announced today that the European Union (EU) has finalized a EUR 3.3 million grant to AIPGENE consortium. Digna Biotech and CIMA will receive, as members of the consortium, EUR 0.5 and EUR 0.8 million respectively for the clinical development of a gene therapy product for Acute Intermittent Porphyria (AIP).
A radioactive bone cement that's injected into bone to provide support and local irradiation is proving to be a safer alternative to conventional radiation therapy for bone tumors, according to a study led by University of California, Irvine researchers.
› Verified 6 days ago
Dr. Nathan D Allison, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 8725 N Wickham Rd, Suite 302, Melbourne, FL 32940 Phone: 321-434-9230 Fax: 321-434-9231 | |
Dr. Olga Dorjima Emgushov, MD,MPH Nephrology Medicare: Medicare Enrolled Practice Location: 1350 Hickory St, Melbourne, FL 32901 Phone: 321-434-1771 Fax: 321-434-1775 | |
Dr. Audrius J Bredikis, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1223 Gateway Dr Ste 2e, Melbourne, FL 32901 Phone: 321-361-5564 Fax: 321-956-2542 | |
Dr. Christopher Ernest Baird, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1350 Hickory St, Melbourne, FL 32901 Phone: 321-434-1771 | |
Craig J Badolato, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1430 Pine St, Melbourne, FL 32901 Phone: 321-674-5050 Fax: 321-952-6296 | |
Dr. Timothy Orphanides, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1223 Gateway Dr Ste 2b, Melbourne, FL 32901 Phone: 321-549-0736 Fax: 321-952-2330 | |
Dr. Caleb Bert Long, D.O. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 250 N Wickham Rd, Melbourne, FL 32935 Phone: 321-338-1618 Fax: 321-433-2311 |